


eleva Revenue
Biotechnology Research • Freiburg, Baden-Württemberg, Germany • 51-100 Employees
eleva revenue & valuation
| Annual revenue | $6,929,955 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $22,200,000 |
| Total funding | $74,000,000 |
Key Contacts at eleva
Björn Cochlovius
Chief Executive Officer
Christian Abraham
Director Strategic Alliances
Andreas Schaaf
Managing Director / Cso
Dénes Zalai
Director Technology
Fabienne Zeitter
Director Corporate Communications
Jana Gross
Director Business Development
Paulina Dabrowska-Schlepp
Director As&T & Nonclinical Development
Sabine Gion
Director People & Culture
Judith Huellebrand
Senior Director Clinical Development
Company overview
| Headquarters | Hans-Bunte-Str. 19, Freiburg, Deutschland (DEU) 79108, DE |
| Phone number | +49761470990 |
| Website | |
| Keywords | Biotechnology, Biopharmaceuticals, Rare Diseases, C3 Glomerulopathy, Complement System, Fabry Disease, C3G, Clinical Assets, Alphagalactosidase, Faktor H, Morbus Fabry, Renal Diseases |
| Founded | 1999 |
| Employees | 51-100 |
| Socials |
eleva Email Formats
eleva uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@elevabiologics.com), used 60.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@elevabiologics.com | 60.5% |
{first name}{last name} | johndoe@elevabiologics.com | 39.5% |
About eleva
Eleva is a clinical-stage biopharmaceutical company unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform. The company’s proprietary drug development activities currently focus on complement disorders and enzyme replacement therapies. Factor H (CPV-104), a recombinant version of human complement Factor H, is expected to enter clinical studies in C3 Glomerulopathy (C3G) in H1 2025. The company’s aGal (RPV-001) program to treat Fabry disease has completed a Phase 1b clinical study with promising results. All programs are sourced from Eleva’s transformative moss-based expression system, which allows lab to GMP-scale manufacturing of challenging proteins with previously untapped therapeutic potential.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
eleva has 25 employees across 9 departments.
Departments
Number of employees
eleva Tech Stack
Discover the technologies and tools that power eleva's digital infrastructure, from frameworks to analytics platforms.
Web servers
PaaS
JavaScript libraries
Hosting
Programming languages
Blogs
Cookie compliance
Databases
Miscellaneous
Performance
Frequently asked questions
4.8
40,000 users



